- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
The post Harmony Biosciences Recognizes World Narcolepsy Day 2026, Reflecting on Nearly a Decade of Commitment to the Sleep Community appeared first on Harmony.
The post Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress appeared first on Harmony.
The post Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference appeared first on Harmony.
The post Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium appeared first on Harmony.
The post Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile appeared first on Harmony.
The post Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026 appeared first on Harmony.
The post Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition appeared first on Harmony.
The post Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting appeared first on Harmony.
The post Harmony Biosciences to Participate in Upcoming Investor Conferences appeared first on Harmony.
The post Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities appeared first on Harmony.